Catalent
Catalent’s global clinical supply network has eight cGMP facilities and over 50 supporting depots, managing more than 150,000 shipments per year to over 80 countries.
Catalent’s global clinical supply network has eight cGMP facilities and over 50 supporting depots, managing more than 150,000 shipments per year to over 80 countries.
Recent multi-million-dollar investment at its sites in Singapore, Philadelphia, and Kansas City has expanded Catalent’s capacity to meet the challenges of today’s complex clinical trial supply demands.
Catalent Pharma Solutions
14 Schoolhouse Rd, Somerset, NJ 08873
tel. 1.888.SOLUTION
solutions@catalent.com
CPhI Worldwide Booth Number: 3D10
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
